Pre-malignant States to Hematologic Malignancies in Firefighters
Recruiting
300 enrolled
REMAKE
Not yet recruiting
300 enrolled
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Recruiting
1,000 enrolled
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
Completed
1,340 enrolled
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Active not recruiting
656 enrolled
MMExFFPE
Not yet recruiting
15 enrolled
A Study of Ninlaro in Real World Clinical Practice in China
Completed
482 enrolled
AI
Enrolling by invitation
10 enrolled
NIRVANA
Completed
36 enrolled
LIBERATE
Recruiting
2,500 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
Completed
419 enrolled
LOOMIS
Completed
67 enrolled 24 charts
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Active not recruiting
250 enrolled
MYRACLE
Recruiting
1,400 enrolled
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Completed
633 enrolled 15 charts
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
Completed
400 enrolled
Longitudinal Data Registry of Plasma Cell Dyscrasia
Recruiting
2,000 enrolled
Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey
Completed
51 enrolled 8 charts
Survivorship
Recruiting
45 enrolled
Mobile Health Device Study for Myeloma Patients
Completed
40 enrolled
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Completed
514 enrolled 16 charts
ASH Research Collaborative Data Hub
Enrolling by invitation
100,000 enrolled
COSMIC
Active not recruiting
200 enrolled
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Completed
508 enrolled 16 charts
HemaTMA
Active not recruiting
5,000 enrolled
FATIGUE
Unknown
40 enrolled
genetics MM
Not yet recruiting
498 enrolled
Bergamo Lymphoid Cancer Registry
Recruiting
6,000 enrolled
Registry PCD
Not yet recruiting
750 enrolled
ORHEO
Completed
2,333 enrolled
ENROL
Recruiting
37,090 enrolled
CoMMpass
Completed
1,154 enrolled
The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures
Completed
1,120 enrolled
GAGNE
Completed
200 enrolled
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyricâ„¢ Flow Cytometer
Completed
208 enrolled
CHIME
Unknown
10 enrolled
Corneal Toxicity in Patients Treated by Belantamab Mafodotin
Completed
43 enrolled
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
Completed
902 enrolled
Changing Over Time of Ascorbic Acid After Chemotherapy
Unknown
150 enrolled
iTIMM
Completed
61 enrolled
Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
Completed
213 enrolled
SPACE2
Unknown
150 enrolled
DECIMA
Not yet recruiting
78 enrolled
THERMAL
Unknown
20 enrolled
Collecting and Storing Blood Samples From Patients With Cancer
Withdrawn
MYMO
Terminated
12 enrolled
Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
Terminated
225 enrolled
ICARE
Unknown
60 enrolled